Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders

Abstract

Introduction Psychiatric and neurologic illnesses are highly prevalent and are often suboptimally treated. A 2015 review highlighted the value of psychiatric pharmacists in improving medication-related outcomes. There is a need to describe areas of expansion and strengthened evidence regarding pharmacist practice and patient care impact in psychiatric and neurologic settings since 2015. Methods A systematic search of literature published from January 2014 to June 2019 was conducted. Publications describing patient-level outcome results associated with pharmacist provision of care in a psychiatric/neurologic setting and/or in relation to central nervous system (CNS) medications were included. Results A total of 64 publications were included. There was significant heterogeneity of published study methods and data, prohibiting meta-analysis. Pharmacists practicing across a wide variety of health care settings with focus on CNS medication management significantly improved patient-level outcomes, such as medication adherence, disease control, and avoidance of hospitalization. The most common practice approach associated with significant improvement in patient-level outcomes was incorporation of psychiatric pharmacist input into the interprofessional health care team. Discussion Pharmacists who focus on psychiatric and neurologic disease improve outcomes for patients with these conditions. This is important in the current health care environment as most patients with psychiatric or neurologic conditions continue to have unmet needs. Additional studies designed to measure pharmacists' impact on patient-level outcomes are encouraged to strengthen these findings.

Impact of a clinical pharmacist on medication safety in mental health Hospital-in-the-Home: a retrospective analysis

“…A future study could, therefore, investigate the effect of CP integration in a MH-HiTH program on patient outcomes, including medication-related hospital readmission rates and ED presentations, utilising the recently developed prescribing safety indicators specific to MH [ 35 ]. Werremeyer et al’s recent review found that the most common factor associated with improving outcomes for patients with psychiatric and neurological conditions was incorporation of an MH CP into an MDT in predominantly inpatient, outpatient and clinic settings [ 36 ]. Future research could explore a novel approach to collect data on how a CP integrates into a MH-HiTH MDT to improve patient care by proactive discussion with MDT members, rather than making retrospective interventions.…”

Positioning psychiatric pharmacists to improve mental health care

“…Psychiatric pharmacists can expand capacity and improve medication-related outcomes through direct interaction with patients, physicians, and other providers using telehealth technology in rural communities particularly impacted by limited access to care. 3 , 7 , 8 …”

Opportunities for pharmacists to impact student health on college campuses

“…24 In addition, the increased use of psychotropic medications on college campuses presents additional opportunities for pharmacists to positively impact patient care. 25 Pharmacists can play a critical role in the treatment and management of psychiatric illnesses on college campuses. A study by Caley and colleagues found that implementation of a psychiatric pharmacist in a university student health system enhanced the clinical care of students and enhanced education among providers.…”